Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
36 hedge funds and large institutions have $18.8M invested in Lumos Pharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 36 → 36 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
19% less capital invested
Capital invested by funds: $23.3M → $18.8M (-$4.51M)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAOI
Wealth Advisors of Iowa
West Des Moines,
Iowa
|
+$187K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$172K |
| 3 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
+$100K |
| 4 |
KFI
Key Financial Inc
West Chester,
Pennsylvania
|
+$87.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$25.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$818K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$253K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$107K |
| 4 |
PAG
Paladin Advisory Group
Clive,
Iowa
|
-$35.1K |
| 5 |
BlackRock
New York
|
-$15.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $22K | -$4.53K | -566 | -17% |
|
27
UBS Group
Zurich,
Switzerland
| $15K | -$1.49K | -186 | -9% |
|
|
APA
28
American Portfolios Advisors
Holbrook,
New York
| $9.63K | – | – | – |
|
|
WFA
29
West Financial Advisors
Des Moines,
Iowa
| $6K | – | – | – |
|
30
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $5K | +$1.77K | +221 | +55% |
|
31
Morgan Stanley
New York
| $3K | -$7.34K | -918 | -73% |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | -$16 | -2 | -0.5% |
|
33
Group One Trading
Chicago,
Illinois
| $1K | – | – | – |
|
34
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $1K | – | – | – |
|
|
35
Citadel Advisors
Miami,
Florida
| – | -$107K | -11,339 | Closed |
|
|
PAG
36
Paladin Advisory Group
Clive,
Iowa
| – | -$35.1K | -4,382 | Closed |
|
|
PFS
37
Prospera Financial Services
Dallas,
Texas
| – | -$10K | -1,088 | Closed |
|
|
CSB
38
City State Bank
Norwalk,
Iowa
| – | -$1K | -111 | Closed |
|
LUMO Hedge Fund Activity: Q2 2022 in Review
36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q2 2022, worth a combined $18.8M — down 19% from $23.3M a quarter earlier.
Fund positioning in LUMO was balanced in Q2 2022: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 11 trimmed.
The largest buyer was Wealth Advisors of Iowa, adding an estimated $187K. The largest seller was NEA Management Company, cutting an estimated $818K.
- 36 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $18.8M of Lumos Pharma, Inc. Common Stock stock for Q2 2022, down 19% quarter-over-quarter.
- 4 funds opened new Lumos Pharma, Inc. Common Stock positions in Q2 2022 and 4 closed out, a net change of 0 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q2 2022 was Wealth Advisors of Iowa, an estimated $187K added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q2 2022 was NEA Management Company, an estimated $818K sold.
Based on aggregated 13F filings for Q2 2022.